Health Care & Life Sciences » Pharmaceuticals | DAE HWA Pharmaceutical Co. Ltd.

DAE HWA Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
5,283
7,971
5,083
14,816
14,588
Total Accounts Receivable
29,821
29,562
27,651
27,685
25,237
Inventories
18,206
18,989
20,927
18,576
13,393
Other Current Assets
2,293
1,267
2,227
901
1,458
Total Current Assets
55,604
57,789
55,888
61,978
54,676
Net Property, Plant & Equipment
49,717
49,308
49,623
70,179
65,968
Total Investments and Advances
9,846
8,851
10,424
10,721
27,599
Long-Term Note Receivable
123
53
49
39
10
Intangible Assets
5,275
6,928
7,707
8,036
14,504
Other Assets
429
-
-
376
129
Total Assets
121,868
124,073
124,609
153,803
166,191
ST Debt & Current Portion LT Debt
20,993
26,787
29,722
47,358
49,176
Accounts Payable
12,699
11,535
11,272
10,602
9,947
Income Tax Payable
658
3,498
1,724
1,547
2,330
Other Current Liabilities
5,588
7,338
5,273
6,029
6,712
Total Current Liabilities
39,938
49,158
47,990
65,536
68,166
Long-Term Debt
12,045
6,111
3,889
2,222
-
Provision for Risks & Charges
6,933
9,178
9,294
10,557
10,568
Deferred Taxes
593
1,145
919
2,474
3,305
Other Liabilities
644
1,121
1,704
2,097
2,634
Total Liabilities
59,840
65,568
62,877
80,412
81,368
Common Equity (Total)
60,393
58,000
61,055
66,151
78,090
Total Shareholders' Equity
60,393
58,000
61,055
66,151
78,090
Total Equity
62,028
58,505
61,732
73,391
84,823
Liabilities & Shareholders' Equity
121,868
124,073
124,609
153,803
166,191
Accumulated Minority Interest
1,634
505
677
7,240
6,733

About DAE HWA Pharmaceutical Co.

View Profile
Address
495 Hanu-ro
Hoengseong-gun GA 25228
Korea, Republic Of
Employees -
Website http://www.dhpharm.co.kr
Updated 09/14/2018
DAE HWA PHARM Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Pharmaceuticals Manufacturing and Distribution, Pharmaceuticals Wholesale, and Pharmaceuticals Materials Manufacturing and Distribution. Its products include cough suppressants, expectorants, and mucolytics, drugs affecting the nervous system, drugs for liver diseases, corticosteroids, and hemorrhoid disease, analgesics, anti-inflammatory, anti-pyretics, vitamins and tonics, plaster, antihistamines, skeletal muscle relaxants, cardiovascular drugs, anti-inflammatory enzymes, gastro-intestinal drugs, iron and calcium supply, topical drugs, and injections.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.